As high plasma cholesterol levels are related to the development of CVD, we determined how different kefir preparations impacted circulating levels of VCAM-1 and CRP, which are important factors in the development of atherosclerosis and common biomarkers of CVD risk. This evidence concerns the gene VCAM1 and atherosclerosis.